Recent News

Novel NeuroLux Optofluidics Device

Monday, November 16, 2020

  NeuroLux has launched the first commercially manufactured Optofluidics device, providing simultaneous drug delivery and optogenetics. It is an implantable, lightweight, battery-free device with parameter control on the individual device level. The device combines soft microfluidic and microscale inorganic light-emitting diode probes for programmable pharmacological and optogenetics, designed to offer the features of drug refillability and adjustable […]

read more »

NeuroLux Remote Workshop

Tuesday, July 28, 2020

NeuroLux is extending its reach to China as the global provider of breakthrough technologies for optogenetics. Its first international remote workshop invites the neuroscience community across China to get familiar with the NeuroLux system, devices and to interact with engineers behind the technology.  Event Details: Platform: Zoom Date: August 11, 2020, or August 12, 2020 […]

read more »

Tuning Made Easy: NeuroLux Launches the Autotuner

Friday, May 31, 2019

NeuroLux has launched the Autotuner, an upgrade to the manual Antenna Tuner Box which matches the impedance of the source and the antenna. This step is crucial to the overall performance of the NeuroLux system, with accurate tuning corresponding to maximized power transfer to the implantable devices in any antenna configuration, and lab environment. However, […]

read more »

NeuroLux to Attend the 2019 Materials Research Society Spring Meeting and Exhibit

Tuesday, April 16, 2019

Come out to Phoenix, Arizona to attend the 2019 Materials Research Society Spring Meeting and Exhibit, where interdisciplinary researchers worldwide come to network and exchange knowledge.  There will be seven different symposium sessions, ranging from topics on colloidal nanoparticles to In Situ experimentation and techniques. Join our CEO, Tony Banks, in symposium session EP02 on […]

read more »

NeuroLux Illuminate Workshop Has Arrived in China

Monday, November 5, 2018

NeuroLux is extending its reach to China as the global provider of breakthrough technologies for optogenetics. Its first international workshop invites the neuroscience community across China to see the system first hand and to interact with researchers behind the technology. Following the event, NeuroLux will start offering the technology in the country to encourage adoption […]

read more »

NeuroLux Hosts Its First Training Workshop

Friday, April 27, 2018

NeuroLux hosted its first training workshop on April 25-26, 2018 at Washington University School of Medicine in St. Louis, Missouri. The NeuroLux Illuminate Workshop 2018 provided attendees the opportunity to become trained on the technology and the surgical procedures, to listen to and interact with guest researchers who have active programs built around the Neurolux technology, […]

read more »

NeuroLux Illuminate 2018: Free technology and surgery training for neuroscientists!

Friday, March 30, 2018

NeuroLux offers the only wireless optogenetics device platform that is fully-implantable, ultralightweight, and battery-free.  These systems dramatically improve and simplify the means for light delivery and control in optogenetics experiments, thereby catalyzing the further adoption of these methodologies by the neuroscience community. This workshop will provide attendees the opportunity to become trained on the technology […]

read more »

Latest Development of an Upcoming Addition to Our Product Portfolio Published in PNAS!

Wednesday, January 31, 2018

Wireless optogenetics technology for neuroscience research has assisted the neuroscience community in controlling neural activation and silencing and catalyzed a desire for powerful synergistic tools. One of the latest advancement in complementary toolsets is the creation of fiber photometry, with capability to optically record neural activity. The currently-available tethered approach imposes physical constraints that restrict […]

read more »

NeuroLux awarded NIH STTR Phase I Grant

Thursday, October 19, 2017

NeuroLux, an early stage biotech company based in Champaign, IL, has been awarded a Small Business Technology Transfer (STTR) Phase I grant by the National Institutes of Health (NIH) to develop wireless, battery-free devices for programmable fluid delivery and optogenetic stimulation, in designs fully compatible with the existing NeuroLux HF wireless electronic platform and control […]

read more »

NeuroLux Spinal Optogenetics System Published in PAIN!

Wednesday, October 11, 2017

This new wireless platform that adapts near-field communication (NFC) technology and microscale LED technologies for optogenetic studies beyond the brain. The reported devices are designed specifically for implantation in a minimally invasive fashion over the mouse spinal cord for wireless and battery-free optogenetic interrogation of spinal circuits in freely moving animals. The studies utilized NeuroLux […]

read more »